Literature DB >> 24272916

An Italian consensus for invasive candidiasis management (ITALIC).

L Scudeller1, C Viscoli, F Menichetti, V del Bono, F Cristini, C Tascini, M Bassetti, P Viale.   

Abstract

INTRODUCTION: Invasive candidiasis (IC) has primarily been studied in intensive care unit (ICU) patients, although, in reality, a vast majority of these infections occur outside of the ICU. The recent publication of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines also deal with the non-ICU population, but many uncertainties remain on the management of IC, particularly in non-critically ill patients.
METHODS: The Italian Society of Antimicrobial Therapy, Società Italiana di Terapia Antimicrobica (SITA), produced practical, hospital-wide recommendations on the management of Candida infection in non-immunocompromised patients in the hospital ward. RESULTS AND DISCUSSION: Our focus is on patient stratification in terms of risk factors for IC and of clinical severity, emphasising a high index of suspicion to ensure early diagnosis, early treatment and de-escalation when a patient is clinically stable, in order to optimise resource allocation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24272916     DOI: 10.1007/s15010-013-0558-0

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  162 in total

1.  Post-diagnostic kinetics of the (1 → 3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia.

Authors:  S Koo; L R Baden; F M Marty
Journal:  Clin Microbiol Infect       Date:  2012-03-08       Impact factor: 8.067

2.  Diagnosis of candidemia by polymerase chain reaction and blood culture: prospective study in a high-risk population and identification of variables associated with development of candidemia.

Authors:  M S Moreira-Oliveira; Y Mikami; M Miyaji; T Imai; A Z Schreiber; M L Moretti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

3.  Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit.

Authors:  Luis Ostrosky-Zeichner; Peter G Pappas; Shmuel Shoham; Annette Reboli; Michelle A Barron; Charles Sims; Craig Wood; Jack D Sobel
Journal:  Mycoses       Date:  2011-01       Impact factor: 4.377

4.  European expert opinion on the management of invasive candidiasis in adults.

Authors:  B J Kullberg; P E Verweij; M Akova; M C Arendrup; J Bille; T Calandra; M Cuenca-Estrella; R Herbrecht; F Jacobs; M Kalin; C C Kibbler; O Lortholary; P Martino; J F Meis; P Muñoz; F C Odds; B E De Pauw; J H Rex; E Roilides; T R Rogers; M Ruhnke; A J Ullmann; Ö Uzun; K Vandewoude; J-L Vincent; J P Donnelly
Journal:  Clin Microbiol Infect       Date:  2011-09       Impact factor: 8.067

Review 5.  Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature.

Authors:  E J Anaissie; R O Darouiche; D Abi-Said; O Uzun; J Mera; L O Gentry; T Williams; D P Kontoyiannis; C L Karl; G P Bodey
Journal:  Clin Infect Dis       Date:  1996-11       Impact factor: 9.079

6.  β-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis.

Authors:  Drosos E Karageorgopoulos; Evridiki K Vouloumanou; Fotinie Ntziora; Argyris Michalopoulos; Petros I Rafailidis; Matthew E Falagas
Journal:  Clin Infect Dis       Date:  2011-03-15       Impact factor: 9.079

7.  Correlates of acute renal failure in patients receiving parenteral amphotericin B.

Authors:  D W Bates; L Su; D T Yu; G M Chertow; D L Seger; D R Gomes; R Platt
Journal:  Kidney Int       Date:  2001-10       Impact factor: 10.612

8.  The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.

Authors:  M H Nguyen; J E Peacock; A J Morris; D C Tanner; M L Nguyen; D R Snydman; M M Wagener; M G Rinaldi; V L Yu
Journal:  Am J Med       Date:  1996-06       Impact factor: 4.965

9.  Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality.

Authors:  Matthew Morrell; Victoria J Fraser; Marin H Kollef
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

10.  Detection of candidaemia in patients with and without underlying haematological disease.

Authors:  M C Arendrup; O J Bergmann; L Larsson; H V Nielsen; J O Jarløv; B Christensson
Journal:  Clin Microbiol Infect       Date:  2009-12-11       Impact factor: 8.067

View more
  17 in total

1.  Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.

Authors:  P Pini; C Bettua; C F Orsi; C Venturelli; F Forghieri; S Bigliardi; L Faglioni; F Luppi; L Serio; M Codeluppi; M Luppi; C Mussini; M Girardis; Elisabetta Blasi
Journal:  Infection       Date:  2015-10-16       Impact factor: 3.553

2.  Evaluation of candidemia and antifungal consumption in a large tertiary care Italian hospital over a 12-year period.

Authors:  Jessica Mencarini; Elisabetta Mantengoli; Lorenzo Tofani; Eleonora Riccobono; Rossella Fornaini; Filippo Bartalesi; Giampaolo Corti; Alberto Farese; Patrizia Pecile; Luca Boni; Gian Maria Rossolini; Alessandro Bartoloni
Journal:  Infection       Date:  2018-04-13       Impact factor: 3.553

3.  Antifungal Treatment Strategies in the ICU: Beyond Meta-analysis.

Authors:  Francesco Giuseppe De Rosa; Silvia Corcione; Giorgia Montrucchio; Luca Brazzi; Giovanni Di Perri
Journal:  Turk J Anaesthesiol Reanim       Date:  2016-12-01

4.  Appropriate Treatment of Invasive Candidiasis in ICU: Timing, Colonization Index, Candida Score & Biomarkers, Towards de-Escalation?

Authors:  Francesco Giuseppe De Rosa; Silvia Corcione; Giorgia Montrucchio; Luca Brazzi; Giovanni Di Perri
Journal:  Turk J Anaesthesiol Reanim       Date:  2016-12-01

Review 5.  Invasive Candida Infections in the ICU: Diagnosis and Therapy.

Authors:  Péter Hankovszky; Domokos Társy; Nándor Öveges; Zsolt Molnár
Journal:  J Crit Care Med (Targu Mures)       Date:  2015-11-10

6.  Nosocomial candidemia in patients admitted to medicine wards compared to other wards: a multicentre study.

Authors:  Roberto Luzzati; Maria Merelli; Filippo Ansaldi; Chiara Rosin; Annamaria Azzini; Silvia Cavinato; Pierluigi Brugnaro; Claudio Vedovelli; Annamaria Cattelan; Busetti Marina; Giuseppe Gatti; Ercole Concia; Matteo Bassetti
Journal:  Infection       Date:  2016-07-11       Impact factor: 3.553

Review 7.  What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead.

Authors:  Matteo Bassetti; Elda Righi; Philippe Montravers; Oliver A Cornely
Journal:  J Antimicrob Chemother       Date:  2018-01-01       Impact factor: 5.790

8.  Population pharmacokinetics of fluconazole in liver transplantation: implications for target attainment for infections with Candida albicans and non-albicans spp.

Authors:  Pier Giorgio Cojutti; Manuela Lugano; Elda Righi; Giorgio Della Rocca; Matteo Bassetti; William Hope; Federico Pea
Journal:  Eur J Clin Pharmacol       Date:  2018-07-21       Impact factor: 2.953

9.  Initial antifungal strategy does not correlate with mortality in patients with candidemia.

Authors:  R Murri; G Scoppettuolo; G Ventura; M Fabbiani; F Giovannenze; F Taccari; E Milozzi; B Posteraro; M Sanguinetti; R Cauda; M Fantoni
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-12-03       Impact factor: 3.267

10.  Candidemia in Colombia

Authors:  Jorge Alberto Cortés; José Franklin Ruiz; Lizeth Natalia Melgarejo-Moreno; Elkin V Lemos
Journal:  Biomedica       Date:  2020-03-01       Impact factor: 0.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.